title: Estimation of Cachexia among Cancer Patients Based on Four Definitions.
abstract: Objectives. Estimate and compare the proportion of cancer patients with cachexia using different definitions from available clinical data. Methods. Electronic medical records were examined to estimate the proportion of cancer patients with cachexia using 4 definitions: (1) ICD-9 diagnostic code of 799.4 (cachexia), (2) ICD-9 diagnosis of cachexia, anorexia, abnormal weight loss, or feeding difficulties, (3) prescription for megestrol acetate, oxandrolone, somatropin, or dronabinol, and (4) >/=5% weight loss. Patients with cancer of the stomach, pancreas, lung, colon/rectum, head/neck, esophagus, prostate, breast, or liver diagnosed between 1999 and 2004 were followed for cachexia. Results. Of 8541 cancer patients (60% men and 55% Caucasian), cachexia was observed in 2.4% of patients using the cachexia diagnostic code, 5.5% expanded diagnoses, 6.4% prescription medication definition, and 14.7% with >/=5% weight loss. Conclusions. The proportion of patients with cachexia varied considerably depending upon the definition employed, indicating that a standard operational definition is needed.
authors: Strategic Healthcare Solutions, LLC, P.O. Box 543, Monkton, MD 21111, USA.
authors: Kathleen M
authors: KM
authors: Fox
authors: John M
authors: JM
authors: Brooks
authors: Shravanthi R
authors: SR
authors: Gandra
authors: Richard
authors: R
authors: Markus
authors: Chiun-Fang
authors: CF
authors: Chiou